UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 403

Sortiert nach

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry

Thrombosis journal, 2020-03, Vol.18 (1), p.5-5, Article 5

2020

Link zum Volltext

Verfügbarkeit prüfen

Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction

Thrombosis research, 2008, Vol.122 (6), p.776-781

2008

Link zum Volltext

Verfügbarkeit prüfen

P2Y12 blocker monotherapy after percutaneous coronary intervention

Netherlands heart journal, 2021-11, Vol.29 (11), p.566-576

2021

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Antiplatelet therapy with CABG: chaos in the Netherlands

Netherlands heart journal, 2017-09, Vol.25 (9), p.481-481

Verheugt, F. W. A.

2017

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

Annals of the rheumatic diseases, 2007-06, Vol.66 (6), p.764-770

2007

Link zum Volltext

Verfügbarkeit prüfen

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)

Netherlands heart journal, 2016-10, Vol.24 (10), p.574-580

2016

Link zum Volltext

Verfügbarkeit prüfen

Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology

European heart journal, 2011-08, Vol.32 (15), p.1854-1864

2011

Link zum Volltext

Verfügbarkeit prüfen

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy

European heart journal, 2013-06, Vol.34 (23), p.1708-1713

2013

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands

Netherlands heart journal, 2016-12, Vol.24 (12), p.768-768

2016

Link zum Volltext

Verfügbarkeit prüfen

Antiplatelet treatment for coronary heart disease

Heart (British Cardiac Society), 2007-02, Vol.93 (2), p.258-265

2007

Link zum Volltext

Verfügbarkeit prüfen

Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The ‘wait a day’ approach might be safer

Netherlands heart journal, 2016-03, Vol.24 (3), p.173-180

2016

Link zum Volltext

Verfügbarkeit prüfen

Triple therapy for percutaneous coronary intervention in atrial fibrillation: standard of care, or a nightmare soon to end?

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (S1), p.S332-S335

Verheugt, F. W. A.

2015

Link zum Volltext

Verfügbarkeit prüfen

Low performance of bleeding risk models in the very elderly with atrial fibrillation using vitamin K antagonists

Journal of thrombosis and haemostasis, 2016-09, Vol.14 (9), p.1715-1724

2016

Link zum Volltext

Verfügbarkeit prüfen

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands

Netherlands heart journal, 2016-10, Vol.24 (10), p.574-580

2016

Link zum Volltext

Verfügbarkeit prüfen

High dose ascorbic acid does not reverse central sympathetic overactivity in chronic heart failure

Journal of clinical pharmacy and therapeutics, 2011-10, Vol.36 (5), p.546-552

2011

Link zum Volltext

Verfügbarkeit prüfen

Lower body positive pressure by anti-G garment inflation: a suitable method to increase pulmonary capillary wedge pressure in healthy elderly subjects

Clinical physiology and functional imaging, 2005-01, Vol.25 (1), p.27-33

2005

Link zum Volltext

Verfügbarkeit prüfen

Bivalirudin Started during Emergency Transport for Primary PCI

The New England journal of medicine, 2013-12, Vol.369 (23), p.2207-2217

2013

Link zum Volltext

Verfügbarkeit prüfen

High platelet reactivity--the challenge of prolonged anticoagulation therapy after ACS

Thrombosis and haemostasis, 2013-05, Vol.109 (5), p.799

2013

Link zum Volltext

Verfügbarkeit prüfen

Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation

International journal of clinical practice (Esher), 2006-09, Vol.60 (9), p.1129-1137

2006

Link zum Volltext

Verfügbarkeit prüfen

Proton‐pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo‐controlled trial

Alimentary pharmacology & therapeutics, 2003-07, Vol.18 (1), p.109-115

2003

Link zum Volltext

Verfügbarkeit prüfen

Prognostic implications of the blood pressure response to the Valsalva manoeuvre in elderly cardiac patients

Heart (British Cardiac Society), 2006-09, Vol.92 (9), p.1327-1328

2006

Link zum Volltext

Verfügbarkeit prüfen

Impact of the papillary muscles on cardiac magnetic resonance image analysis of important left ventricular parameters in hypertrophic cardiomyopathy

Netherlands heart journal, 2016-05, Vol.24 (5), p.326-331

2016

Link zum Volltext

Verfügbarkeit prüfen

Acute myocardial infarction due to an acute type A aortic dissection involving the left main coronary artery

Netherlands heart journal, 2007-08, Vol.15 (7-8), p.263-264

2007

Link zum Volltext

Verfügbarkeit prüfen

The new oral anticoagulants in atrial fibrillation: an update

Netherlands heart journal, 2013-11, Vol.21 (11), p.480-484

Verheugt, F. W. A.

2013

Link zum Volltext

Verfügbarkeit prüfen

Trials, registries and guidelines for non-ST-elevation acute coronary syndromes

Netherlands heart journal, 2014-02, Vol.22 (2), p.52-54

Verheugt, F W A

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 403

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(315)
Mit Volltextzugriff
(336)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(268)
Life Sciences & Biomedicine
(246)
Science & Technology
(246)
Cardiovascular System & Cardiology
(175)
Cardiac & Cardiovascular Systems
(159)
Male
(144)
Biological And Medical Sciences
(139)
Medical Sciences
(136)
Female
(134)
Middle Aged
(123)
Aged
(106)
Cardiology. Vascular System
(63)
Myocardial Infarction - Drug Therapy
(62)
Pharmacology. Drug Treatments
(58)
Treatment Outcome
(58)
Heart
(57)
Risk Factors
(52)
Platelet Aggregation Inhibitors - Therapeutic Use
(48)
Coronary Heart Disease
(44)
General & Internal Medicine
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry

Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction

P2Y12 blocker monotherapy after percutaneous coronary intervention

Erratum to: Antiplatelet therapy with CABG: chaos in the Netherlands

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)

Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy

Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands

Antiplatelet treatment for coronary heart disease

Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The ‘wait a day’ approach might be safer

Triple therapy for percutaneous coronary intervention in atrial fibrillation: standard of care, or a nightmare soon to end?

Low performance of bleeding risk models in the very elderly with atrial fibrillation using vitamin K antagonists

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands

High dose ascorbic acid does not reverse central sympathetic overactivity in chronic heart failure

Lower body positive pressure by anti-G garment inflation: a suitable method to increase pulmonary capillary wedge pressure in healthy elderly subjects

Bivalirudin Started during Emergency Transport for Primary PCI

High platelet reactivity--the challenge of prolonged anticoagulation therapy after ACS

Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation

Proton‐pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo‐controlled trial

Prognostic implications of the blood pressure response to the Valsalva manoeuvre in elderly cardiac patients

Impact of the papillary muscles on cardiac magnetic resonance image analysis of important left ventricular parameters in hypertrophic cardiomyopathy

Acute myocardial infarction due to an acute type A aortic dissection involving the left main coronary artery

The new oral anticoagulants in atrial fibrillation: an update

Trials, registries and guidelines for non-ST-elevation acute coronary syndromes

Suchergebnisse filtern